You are about to leave Helsinn's Corporate US Website.

Please click 'Continue to external site' if you want to continue.

Solid Tumors

Learn more about our portfolio of services and innovative therapies by visiting the product websites or viewing the full prescribing information.

QED Therapeutics, Inc. holds the NDA for TRUSELTIQ™.  TRUSELTIQ™ is a trademark of QED Therapeutics and co-marketed in the U.S. by Helsinn Therapeutics (U.S.), Inc. and QED Therapeutics.   

This product is approved in the US only.